| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Adenocarcinoma (non-small cell lung cancer) | 5 | 0 | |
| Lung cancer | 2 | 0 | |
| Squamous cell carcinoma (non-small cell lung cancer) | 2 | 0 | |
| Non-small cell lung cancer | 1 | 0 | |
| Salivary gland-like carcinoma (non-small cell lung cancer) | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Fluid retention (edema) | 1 |